Literature DB >> 16919773

Retinoblastoma incidence and survival in European children (1978-1997). Report from the Automated Childhood Cancer Information System project.

A MacCarthy1, G J Draper, Eva Steliarova-Foucher, J E Kingston.   

Abstract

Based on 2283 cases of retinoblastoma diagnosed in children aged 0-14 years, incidence and survival in Europe during the period 1978-1997 are described. Data were provided to the Automated Childhood Cancer Information System (ACCIS) from 60 paediatric and general cancer registries. During 1988-1997, the cumulative incidence of retinoblastoma in the ACCIS regions was found to be between 44.2 and 67.9 per million births. The highest incidence was seen in the first year of life. The age-standardised (World standard) incidence rate for the age-range 0-14 years was 4.1 per million. Approximately one-third of cases had bilateral tumours. Overall incidence increased over the period 1978-1997 by 1% per year, as derived from a model adjusted for sex, age group and type of registry (general or paediatric). The 5-year survival rate improved from 89% to 95% during the period covered by the study. This improvement was seen in both unilateral and bilateral cases but was significant only for the unilateral tumours. Survival was lower in the East region, although smaller differences were also observed between the other four regions (British Isles, North, South and West). Availability and quality of registration data on retinoblastoma need to be improved for effective evaluation of incidence and survival.

Entities:  

Mesh:

Year:  2006        PMID: 16919773     DOI: 10.1016/j.ejca.2006.06.003

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  24 in total

1.  Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.

Authors:  Flore Salviat; Marion Gauthier-Villars; Matthieu Carton; Nathalie Cassoux; Livia Lumbroso-Le Rouic; Catherine Dehainault; Christine Levy; Lisa Golmard; Isabelle Aerts; François Doz; Fidéline Bonnet-Serrano; Stéphanie Hayek; Alexia Savignoni; Dominique Stoppa-Lyonnet; Claude Houdayer
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

2.  Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.

Authors:  Gabriella Livide; Maria Carmela Epistolato; Mariangela Amenduni; Vittoria Disciglio; Annabella Marozza; Maria Antonietta Mencarelli; Paolo Toti; Stefano Lazzi; Theodora Hadjistilianou; Sonia De Francesco; Alfonso D'Ambrosio; Alessandra Renieri; Francesca Ariani
Journal:  Pathol Oncol Res       Date:  2012-01-26       Impact factor: 3.201

3.  The National Registry of Retinoblastoma in Japan (1983-2014).

Authors: 
Journal:  Jpn J Ophthalmol       Date:  2018-05-30       Impact factor: 2.447

Review 4.  Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma.

Authors:  Emily S Tonorezos; Danielle Novetsky Friedman; Dana Barnea; Machteld I Bosscha; Guillermo Chantada; Charlotte J Dommering; Pim de Graaf; Ira J Dunkel; Armida W M Fabius; Jasmine H Francis; Mary-Louise C Greer; Ruth A Kleinerman; Wijnanda A Kors; Suzanne Laughlin; Annette C Moll; Lindsay M Morton; Petra Temming; Margaret A Tucker; Flora E van Leeuwen; Michael F Walsh; Kevin C Oeffinger; David H Abramson
Journal:  Ophthalmology       Date:  2020-05-15       Impact factor: 12.079

5.  Retinoblastoma: concerning its initiation and treatment.

Authors:  Chang Luo; Ying-Ping Deng
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

Review 6.  [Retinoblastoma and retinocytoma (retinoma)].

Authors:  K A Metz; D Westerwick; F Driever; K W Schmid; C H D Le Guin
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

7.  microRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A.

Authors:  Jianjun Li; Yinghui Zhang; Xiuchao Wang; Ruibo Zhao
Journal:  Oncol Lett       Date:  2017-04-24       Impact factor: 2.967

8.  Presentation of retinoblastoma at a paediatric eye clinic in ghana.

Authors:  V Essuman; C T Ntim-Amponsah; S Akafo; L Renner; L Edusei
Journal:  Ghana Med J       Date:  2010-03

9.  Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study.

Authors:  La-Ongsri Atchaneeyasakul; Chutima Wongsiwaroj; Mongkol Uiprasertkul; Kleebsabai Sanpakit; Kullathorn Thephamongkhol; Adisak Trinavarat
Journal:  Jpn J Ophthalmol       Date:  2009-01-30       Impact factor: 2.447

10.  miR-498 promotes cell proliferation and inhibits cell apoptosis in retinoblastoma by directly targeting CCPG1.

Authors:  Ling Yang; Ning Wei; Li Wang; Xiang Wang; Qing-Huai Liu
Journal:  Childs Nerv Syst       Date:  2017-12-15       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.